| abstract |
COMBINED THERAPY FOR CANCER. The present disclosure provides methods of administering antibodies and antigen-binding fragments thereof, which specifically bind human B7-H4, to a subject in need, e.g., a cancer patient, in combination with a PD-1 antagonist. /PD-L1, such as an anti-PD-1 antibody. |